(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONKOMEDEOR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ONKOMEDEOR

ST13

US500000079270884

Class

44

Filing

79270884

Registration

6242009

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

01/13/2026

Trademark type

Combined

Nice classes

44

Filing date

09/13/2019

Registration date

01/12/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/12/2021

Last transaction

01/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

01

Owner location

DE

Examiner

DYER,ERIN ZASKODA

Law office

L30

Current location

TMEG LAW OFFICE 103

Mark description

The mark consists of the stylized wording "ONKOMEDEOR", with the "ONKO" as well as half of the letter "M" displayed in yellow and with the "EDEOR" and remaining half of the letter "M" displayed in gray.

Holders and representatives

Holders

D. H. (pessoa física)

Representatives

Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell, & Berkowitz, PC

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical services; medical services for the diagnosis of conditions of the human body * in the field of oncology; * medical services in the field of oncology; medical services in the field of in-patient and out-patient oncology; providing cancer screening services; medical analysis for diagnosticprognostic and treatment purposes provided by medical laboratories and clinics; medical analysis for cancer diagnosisprognosis and treatment; providing medical data and information to healthcare professionals * in the field of oncology *

Publications

History of USPTO decisions and trademark events.

40 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/12/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/14/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/26/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/22/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/30/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/06/2021

FIMP

FINAL DISPOSITION PROCESSED

05/06/2021

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

04/22/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/22/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/22/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/12/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

03/20/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

01/12/2021

GPNX

NOTIFICATION PROCESSED BY IB

12/12/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/20/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/27/2020

PUBO

PUBLISHED FOR OPPOSITION

10/27/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/07/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/07/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/23/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/02/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/02/2020

ALIE

ASSIGNED TO LIE

08/26/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/06/2020

RFNT

REFUSAL PROCESSED BY IB

02/28/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/12/2020

RFRR

REFUSAL PROCESSED BY MPU

02/12/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/17/2020

CNRT

NON-FINAL ACTION WRITTEN

01/16/2020

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

01/14/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/19/2019

CNRT

NON-FINAL ACTION WRITTEN

12/18/2019

DOCK

ASSIGNED TO EXAMINER

12/13/2019

MAFR

APPLICATION FILING RECEIPT MAILED

11/12/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/08/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/31/2019

Continuous trademark protection

Get notified about every new filing that threatens ONKOMEDEOR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.